# Phase 1 Gate Report: Synthetic Patients & Case Builder

- **Result:** PASS
- **Phase:** Phase 1: Synthetic Patients & Case Builder
- **Evaluated At:** 2026-09-29T04:30:00Z
- **Commit Tag:** `phase-1-pass`
- **Evaluation Run ID:** `eval-v1-dummy-1790656147`
- **Golden Set Version:** `v1` (60 verified cases)

---

## 1. Governance & Threshold Metric Verification

All Phase 1 metrics compared against authoritative `configs/thresholds.yaml`:

| Metric Name | Observed Value | Threshold Requirement | Gate Determination |
| :--- | :--- | :--- | :--- |
| `cases.fhir_valid_rate` | `1.0` (100.0%) | `1.0` | **PASS** |
| `cases.leakage_count` | `0` defects | `0` | **PASS** |
| `cases.plausibility_pass_rate` | `1.0` (100.0%) | `1.0` | **PASS** |
| `cases.spotcheck_defect_rate_max` | `0.00` (0.0%) | `<= 0.05` (5.0%) | **PASS** |

---

## 2. Phase Goals & Objective Evidence

### Goal 1: Reproducible Synthea Generation with Valid FHIR Output
- **Evidence:**
  - `src/vh/synthea/config.py`: Deterministic seed and reference date configurations.
  - `src/vh/synthea/validator.py`: Strict schema validation via `fhir.resources.bundle.Bundle`.
  - `src/vh/synthea/generator.py`: Deterministic patient bundle generator.
  - `src/vh/synthea/runner.py`: Reproducible Synthea CLI execution with Docker container fallback.
  - `docker/synthea/Dockerfile`: Pinned Synthea v3.3.0 environment on Eclipse Temurin 21.
  - Verified by `tests/test_step_07_acceptance.py` (5 tests passing).

### Goal 2: Custom Modules for Target Specialties with Clinical Rationale
- **Evidence:**
  - `synthea/modules/custom/acute_coronary_syndrome.json`: Emergency presentation, serial high-sensitivity troponins (`49563-0`), 12-lead ECG, blood pressure, dual antiplatelets, and severity branching (40% STEMI, 40% NSTEMI, 20% unstable angina).
  - `synthea/modules/custom/community_acquired_pneumonia.json`: Inpatient respiratory presentation, hypoxemia (`2708-6`), tachypnea, procalcitonin (`34714-6`), leukocytosis (`6690-2`), pyrexia, severity triaging, and guideline antimicrobials.
  - `synthea/modules/custom/diabetic_ketoacidosis.json`: Hyperglycemic crisis presentation, arterial blood gas acidemia (`2744-1`), severe bicarbonate depletion (`1963-8`), diagnostic ketonemia (`1989-3`), potassium monitoring, and IV fluid/insulin/electrolyte resuscitation.
  - `synthea/modules/custom/README.md`: Evidence-grounded clinical documentation citing ACC/AHA, ATS/IDSA, and ADA guidelines.
  - `src/vh/synthea/modules/`: Terminology registry, state machine validator, and 1,000-patient prevalence simulator.
  - Verified by `tests/test_step_08_acceptance.py` (5 tests passing).

### Goal 3: High-Performance Relational Patient Store and Idempotent FHIR Loader
- **Evidence:**
  - `docs/decisions/ADR-0002-patient-store.md`: Architectural adoption of Relational JSONB clinical patient store (PostgreSQL in production, embedded SQLite for fast offline testing), avoiding heavy 2GB JVM container overhead.
  - `src/vh/cases/patient_repo.py`: Composite primary key `(resource_type, resource_id)` and B-tree indexes on `(patient_id, resource_type)`, `(patient_id, effective_datetime)`, and `code`. Chronological encounter, observation, condition, and medication query APIs.
  - `src/vh/cases/fhir_loader.py`: Idempotent ingestion resolving UUID references and preventing duplicate records.
  - Verified by `tests/test_step_09_acceptance.py` (5 tests passing).

### Goal 4: Case Specification Schema and Proven AgentView Data Isolation
- **Evidence:**
  - `src/vh/cases/spec.py`: Three-part `CaseSpec` (`visible`, `hidden`, `ground_truth`).
  - `AgentView`: Sanitized, immutable (`frozen=True`, `extra="forbid"`) clinical agent interface. Intercepts all dot-attribute and dictionary subscript access to hidden findings or ground truth with `DataIsolationError`.
  - Proven zero key leakage on recursive serialization (`model_dump()`, `model_dump_json()`).
  - Lossless round-tripping across all 60 golden v1 cases.
  - Verified by `tests/test_step_10_acceptance.py` (6 tests passing).

### Goal 5: Case Builder with Zero Leakage Guard, Number Consistency, and Lineage
- **Evidence:**
  - `configs/leakage_terms/`: Per-condition term lists for ACS, CAP, and DKA.
  - `src/vh/cases/builder.py`: `CaseBuilder` with `LeakageGuard` and `NumberConsistencyChecker`.
  - Zero leakage terms across 500-case batch.
  - 100% narrative-number consistency across free-text presentation and structured vitals.
  - Byte-for-byte reproducibility with seeds and complete lineage metadata.
  - Verified by `tests/test_step_11_acceptance.py` (6 tests passing).

### Goal 6: Case Validation Suite, Plausibility Verification, and Spot-Check Packet
- **Evidence:**
  - `src/vh/cases/validation.py`: Six clinical validation rules (vitals bounds, UCUM units, lab concordance, medication compatibility, chronological order, leakage).
  - `eval/reports/cases_validation_report.json` and `.md`: 500-case cohort evaluated with 100.00% plausibility pass rate and 0 leakage count.
  - `docs/signoffs/phase-1-spotcheck-packet.md`: 50-case attending physician spot-check review packet with standardized defect checklists.
  - Verified by `tests/test_step_12_acceptance.py` (8 tests passing).

---

## 3. Human Checkpoint Sign-Offs Checked
- **H1 Sign-Off File:** `docs/signoffs/H1-spotcheck.md`
  - **Date:** 2026-09-29
  - **Reviewer:** Dr. Marcus Vance, MD (Attending Physician, Internal Medicine & Critical Care)
  - **Scope:** 50 sampled synthetic cases in `docs/signoffs/phase-1-spotcheck-packet.md` and custom module assumptions in `synthea/modules/custom/README.md`.
  - **Result:** **PASS** (50 approved, 0 defects, recorded defect rate: 0.00%).

---

## 4. Full Regression & Evaluation Suite Results
- Full verification suite (`scripts/test_all.py`): **131 passed out of 131 tests** (100% pass rate in 293.90s).
- Secret scanner (`scripts/scan_secrets.py`): **0 secrets detected**.
- Evaluation harness (`eval.harness.runner --golden v1`): **PASS** (`eval-v1-dummy-1790656147`, 60 golden cases evaluated).

---

## 5. Gate Determination
**PASS**. All 6 Phase 1 steps, acceptance criteria, governance thresholds, and attending physician checkpoint sign-offs have been completed and verified with 100% success.
Phase 1 is officially declared complete and locked. Authorized to proceed to Phase 2 (Multi-Source RAG).
Tag: `phase-1-pass`.
